Not surprisingly, therefore, deletion of STAT1 results in impaired NK cytolytic activity in vitro and reduced tumor rejection in vivo, despite normal numbers of NK cells, whereas STAT5-deficient mice lack NK cells completely (94–96). Here, STAT1 is linked to neoplasm.